Clinical Trials Directory

Trials / Completed

CompletedNCT00767676

Contact Sensitization Potential of 828 Ointment

Evaluation of the Contact Sensitization Potential of 828 Ointment in Normal Healthy Adults

Status
Completed
Phase
Phase 1
Study type
Interventional
Enrollment
259 (actual)
Sponsor
Healthpoint · Industry
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Accepted

Summary

Contact sensitization by patch applications.

Detailed description

Single site study that will evaluate the contact sensitization potential of 828 ointment by repetitive patch applications to the skin of normal, healthy volunteers.

Conditions

Interventions

TypeNameDescription
DEVICEHP828-101Nine topical patch applications over 3 weeks, rest period of 2 weeks and challenge after 48 hours.

Timeline

Start date
2008-10-01
Primary completion
2008-11-01
Completion
2008-11-01
First posted
2008-10-07
Last updated
2014-06-27
Results posted
2014-06-27

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00767676. Inclusion in this directory is not an endorsement.

Contact Sensitization Potential of 828 Ointment (NCT00767676) · Clinical Trials Directory